{"title":"作为治疗糖尿病、癌症和心血管疾病药物的 AMPK 激活剂","authors":"Mark Goodman, Zhenling Liu, Ping Zhu, Ji Li","doi":"10.4172/2167-7689.1000118","DOIUrl":null,"url":null,"abstract":"<p><p>The cellular mechanisms of AMP-Activated Protein Kinase (AMPK) activators in the treatment and prevention of diabetes, cancer, and cardiovascular disease.</p>","PeriodicalId":74429,"journal":{"name":"Pharmaceutical regulatory affairs : open access","volume":"3 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966671/pdf/","citationCount":"0","resultStr":"{\"title\":\"AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease.\",\"authors\":\"Mark Goodman, Zhenling Liu, Ping Zhu, Ji Li\",\"doi\":\"10.4172/2167-7689.1000118\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The cellular mechanisms of AMP-Activated Protein Kinase (AMPK) activators in the treatment and prevention of diabetes, cancer, and cardiovascular disease.</p>\",\"PeriodicalId\":74429,\"journal\":{\"name\":\"Pharmaceutical regulatory affairs : open access\",\"volume\":\"3 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966671/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical regulatory affairs : open access\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2167-7689.1000118\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/4/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical regulatory affairs : open access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-7689.1000118","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/4/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease.
The cellular mechanisms of AMP-Activated Protein Kinase (AMPK) activators in the treatment and prevention of diabetes, cancer, and cardiovascular disease.